Stem Cell Therapy
Stem Cell Therapy - Related Videos
22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
0 Views •
Cited by 8 •
2007
This protocol details the derivation of transplantable hematopoietic stem cells from mouse embryonic stem cells (ESC) and their subsequent injection into lethally irradiated recipient mice. Briefly, ESC are differentiated as embryoid bodies, which are then infected with retroviral HoxB4 and co-cultured with OP9 stromal cells and hematopoietic cytokines.
01:21
Stem Cell Therapy for Tissue Regeneration
0 Views •
2023
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells. Types of Stem Cells used in Stem Cell Therapy The two main cell types that...
06:59
Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
0 Views •
Cited by 35 •
2012
The generation and characterization of tumor specific T cells using humanized mice is described here. Human thymic tissue and genetically modified human hematopoietic stem cells are transplanted into immunocompromised mice. This results in the reconstitution of an engineered human immune system allowing for in vivo examination of anti-tumor immune responses.
10:03
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
0 Views •
Cited by 30 •
2014
Induced pluripotent stem cell (iPSC)-derived myogenic progenitors are promising candidates for cell therapy strategies to treat muscular dystrophies. This protocol describes transplantation and functional measurements required to evaluate the engraftment and differentiation of iPSC-derived mesoangioblasts (a type of muscle progenitors) in mouse models of acute and chronic muscle regeneration.
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
0 Views •
Cited by 27 •
2015
Pancreatic cancer stem cells (CSCs) can be expanded in vitro using the anchorage-independent sphere culture technique, which represents a powerful tool to study CSC biology and can serve as the first step to develop novel CSC-targeting therapies. Here the methodology for expanding, analyzing and targeting of pancreatic CSCs is provided.
FAQs
After transplantation, the tissue environment and regulatory signals influence whether stem cells survive, migrate, and mature. The cell source also changes this response, so identical delivery strategies may not produce identical behavior. These interactions are central to therapy because successful repair depends not only on placing cells in the body, but also on directing what they do afterward.
Controlling cell identity is a major biological challenge. Stem cells must produce the intended specialized cell type while maintaining appropriate regulation during maturation. Research therefore examines signals that guide differentiation and the conditions that support survival and integration. Better control could improve function while reducing uncertainty about how transplanted cells behave in damaged tissue.
Stem Cell Therapy has a clearer clinical role when hematopoietic stem cell transplantation rebuilds blood-forming tissue after certain diseases or treatments. By contrast, many other regenerative applications remain under investigation. This distinction reflects different levels of evidence and control, not simply a difference in the ability of stem cells to differentiate.
A conceptual workflow begins by considering the cell source, then evaluating how cells will be delivered and whether the target tissue can support survival, migration, maturation, and integration. Immune compatibility must also be addressed. These checkpoints organize research and help investigators connect the selected cells and transplantation conditions with expected biological outcomes.
Outcomes depend on linked variables rather than cell placement alone. Source affects cell behavior, while the tissue environment and regulatory signals influence persistence and maturation. Delivery, integration, and immune compatibility are additional priorities. Studying these factors helps explain why a therapy may restore function in one setting yet require further development in another.
In biology, hematopoietic stem cell transplantation demonstrates an established use of regenerative cell-based treatment: rebuilding blood-forming tissue after certain diseases or treatments. Other proposed uses are assessed through research on cell identity, delivery, integration, and immune compatibility. The resulting goal is safer, more predictable restoration of function across regenerative medicine.